198 related articles for article (PubMed ID: 3706931)
1. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome.
McGovern B; Garan H; Ruskin JN
Ann Intern Med; 1986 Jun; 104(6):791-4. PubMed ID: 3706931
[TBL] [Abstract][Full Text] [Related]
2. [Wolff-Parkinson-White syndrome and verapamil: apropos of a case of ventricular fibrillation].
Michel B; Goy JJ; Kappenberger L
Schweiz Med Wochenschr; 1989 May; 119(19):630-4. PubMed ID: 2740877
[TBL] [Abstract][Full Text] [Related]
3. Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation.
Strasberg B; Sagie A; Rechavia E; Katz A; Ovsyscher IA; Sclarovsky S; Agmon J
Cardiovasc Drugs Ther; 1989 Jan; 2(6):801-6. PubMed ID: 2488095
[TBL] [Abstract][Full Text] [Related]
4. Onset of atrial fibrillation during antidromic tachycardia: association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome.
Cosio FG; Benson DW; Anderson RW; Hession WT; Pritzker MR; Kriett JM; Benditt DG
Am J Cardiol; 1982 Aug; 50(2):353-9. PubMed ID: 7102563
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
Gulamhusein S; Ko P; Carruthers SG; Klein GJ
Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
[TBL] [Abstract][Full Text] [Related]
6. [2 episodes of ventricular fibrillation in a patient with mild paroxysms of Wolff-Parkinson-White syndrome].
Walczak F; Nyznyk M; Biederman A; Jedynak Z; Bujnowska E
Kardiol Pol; 1992 Nov; 37(11):311-3. PubMed ID: 1287293
[TBL] [Abstract][Full Text] [Related]
7. [Administration of adenosine for termination of atrioventricular nodal reentry tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway and unmasking of concomitant Wolff-Parkinson-White syndrome].
Drescher S; Bosch RF; Mewis C; Kühlkamp V
Z Kardiol; 2000 Jun; 89(6):522-6. PubMed ID: 10929437
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.
Hu J; Yu J; Chen Q; Hu J; Huang Q; Xia Z; Xia Z; Ju Z; Yuan P; Fan S; Xiong Q; Zhu B; Huang L; You C; Bao H; Wu Y; Cheng X; Li J; Marian AJ; Hong K
J Am Heart Assoc; 2019 Jul; 8(13):e012511. PubMed ID: 31234695
[TBL] [Abstract][Full Text] [Related]
9. Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation.
Jacob AS; Nielsen DH; Gianelly RE
Ann Emerg Med; 1985 Feb; 14(2):159-60. PubMed ID: 3970402
[TBL] [Abstract][Full Text] [Related]
10. Multiple mechanisms of tachycardias in a patient with the Wolff-Parkinson-White syndrome.
Rubenson DS; Akhtar M; Lau SH; Caracta AR; Damato AN
J Electrocardiol; 1979; 12(2):221-6. PubMed ID: 458292
[TBL] [Abstract][Full Text] [Related]
11. Encainide for treatment of supraventricular tachycardias associated with the Wolff-Parkinson-White syndrome.
Markel ML; Prystowsky EN; Heger JJ; Miles WM; Fineberg N; Zipes DP
Am J Cardiol; 1986 Aug; 58(5):41C-48C. PubMed ID: 3092619
[TBL] [Abstract][Full Text] [Related]
12. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
[TBL] [Abstract][Full Text] [Related]
13. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Swerdlow CD; Peterson J; Liem LB
Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208
[TBL] [Abstract][Full Text] [Related]
14. Augmented ventricular rate following verapamil treatment for atrial fibrillation with Wolff-Parkinson-White syndrome.
Rowland TW
Pediatrics; 1983 Aug; 72(2):245-6. PubMed ID: 6866612
[No Abstract] [Full Text] [Related]
15. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
Bennett DH
Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
[TBL] [Abstract][Full Text] [Related]
16. Wolff-Parkinson-White syndrome presenting in atrial fibrillation.
Schatz I; Ordog GJ; Karody R; Bhasin V
Ann Emerg Med; 1987 May; 16(5):574-8. PubMed ID: 3565873
[TBL] [Abstract][Full Text] [Related]
17. [Risk of ventricular fibrillation in patients with Wolff-Parkinson White syndrome].
Bootsma M; van der Wall EE; Schalij MJ
Ned Tijdschr Geneeskd; 2003 Apr; 147(15):708-14. PubMed ID: 12722534
[TBL] [Abstract][Full Text] [Related]
18. Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
Klein GJ; Bashore TM; Sellers TD; Pritchett EL; Smith WM; Gallagher JJ
N Engl J Med; 1979 Nov; 301(20):1080-5. PubMed ID: 492252
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation with wide QRS tachycardia and undiagnosed Wolff-Parkinson-White syndrome: diagnostic and therapeutic dilemmas in a pediatric patient.
Panduranga P; Al-Farqani A; Al-Rawahi N
Pediatr Emerg Care; 2012 Nov; 28(11):1227-9. PubMed ID: 23128652
[TBL] [Abstract][Full Text] [Related]
20. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
Simonian SM; Lotfipour S; Wall C; Langdorf MI
Intern Emerg Med; 2010 Oct; 5(5):421-6. PubMed ID: 20437113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
